trending Market Intelligence /marketintelligence/en/news-insights/trending/ggOsbrkwfisSyI8W1M-fwA2 content esgSubNav
Log in to other products


Looking for more?

Contact Us
In This List

OptimizeRx prices $20M common stock offering


Q1 2021 Global Capital Markets Activity: SPAC IPOs, Issuance in Consumer Discretionary Sector Surge


COVID-19 Impact & Recovery: Private Equity

COVID-19 Impact & Recovery: Corporates


COVID-19 Impact & Recovery: Investment Banking

OptimizeRx prices $20M common stock offering

OptimizeRx Corp. priced its public offering of 1,538,500 common shares at $13 each.

The Rochester, Mich.-based digital health messaging company also granted the underwriters a 30-day option to buy up to an additional 230,775 common shares at the same price.

Gross proceeds from the offering are expected to be about $20 million. Net proceeds will be used for general corporate purposes, which may include acquisitions.

William Blair & Co. LLC is acting as sole book-running manager for the offering, while B. Riley FBR is acting as lead manager. Roth Capital Partners and Lake Street Capital Markets LLC are acting as financial advisers for the offer.